Chatbots for mental health pose new challenges for US regulatory framework

FHS
May 1, 2024
10:41 am

The regulatory gaps and potential health risks of artificial intelligence (AI)-driven wellness apps.

Aqemia wins $32.5m for generative AI-powered drug discovery platform – Pharmaceutical Technology

Share this article The company spun out of École normale supérieure in 2019 with already assimilated knowledge of quantum physics algorithms. Image credit: Shutterstock/TSViPhoto. Paris-based

January 30, 2024

Can Arena Bioworks upend the traditional scientific research model in the U.S.?

I’ve spent a good deal of my career thinking about how we structure and fund research in the biomedical sciences in the U.S. and questioning

February 2, 2024

Exploring drug shortages in European markets: the causes, analysis, and response – Pharmaceutical Technology

Since 2023, the pharmaceutical industry operating in Europe has faced an unprecedented challenge related to drug shortages. Previously, shortages were dictated by production capacity and

November 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.